US 11660328
GLP-2 analogs and peptibodies for administration before, during or after surgery
granted A61KA61K38/26A61K47/6811
Quick answer
US patent 11660328 (GLP-2 analogs and peptibodies for administration before, during or after surgery) held by Takeda Pharmaceutical Company Limited expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/26, A61K47/6811, A61P, A61P1/00